Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07454434
Eligibility Criteria:
Inclusion Criteria:
* Admitted to the coronary care unit with a diagnosis of MI,
* Aged 18 years or older,
* Conscious, oriented, and cooperative,
* Able to read and understand Turkish,
* Agreeing to participate in the study,
* Having no physical condition that would prevent listening to music,
* Having no diagnosis of hearing loss,
* Not using a hearing aid,
* Having no diagnosis of anxiety disorder,
* Not diagnosed with a sleep disorder,
* Not taking medication for anxiety or sleep disorders,
* Without mental illness,
* With a State Anxiety Scale (SAS) total score of 60 or below,
* Who agree to participate in the study (by signing the Informed Consent Form) will be included.
Exclusion Criteria:
* Admitted to the coronary care unit (CCU) for reasons other than MI diagnosis,
* Under 18 years of age,
* Unconscious, disoriented, and uncooperative,
* Unable to read and understand Turkish,
* Refusing to participate in the study,
* Having a physical condition that prevents listening to music,
* Diagnosed with hearing loss,
* Using a hearing aid,
* Diagnosed with an anxiety disorder or taking medication for anxiety,
* Diagnosed with a sleep disorder or taking medication for a sleep disorder,
* With a mental disorder,
* With a State Anxiety Scale (SAS) total score of 60 or above,
* Patients who do not agree to participate in the study (who do not sign the Informed Consent Form) will not be included in the study.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07454434
Study Brief:
Protocol Section:
NCT07454434